Effects of combined estrogen/testosterone therapy on bone and body composition in oophorectomized women

References

• Michaelsson K, Baron JA, Farahmand BY. Hormone replace-ment therapy and risk of hip fracture: population-based case—control study. Br Med J 1998;316:1858–1863.
   Google Scholar
• Lufkin EG, Wahner HW, O'Fallon WM. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1994;117:1–9.
   Google Scholar
• Ortolani S, Trevisan C, Bianchi ML. Spinal and forearm bone mass in relation to ageing and menopause in healthy Italian women. Eur J Clin Invest 1991;21:33–39.
   Google Scholar
• Vanderschueren D, Vandenput L, Boonen S. Androgens and bone. Endocr Rev 2004;25:389–425.
   PubMed Web of Science ®Google Scholar
• Lindsay R, Hart DM, Forrest C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;2:1151–1154.
   Google Scholar
• Genant HK, Cann CE, Ettinger B. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982;97:699–705.
   Google Scholar
• Judd HL, Judd GE, Lucas EE. Endocrine function of the postmenopausal ovary: concentrations of androgens and estrogens in ovarian and peripheral vein blood. J Endocrinol Metab 1974;39:1020–1024.
   Google Scholar
• Davis SR, McCloud PI, Strauss BJG. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227–236.
   Google Scholar
• Shifren, JL, Braunstein GD, Simon JA. Transdermal testos-terone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682–688.
   PubMed Web of Science ®Google Scholar
• Flöter A, Nathorst-Böös J, Carlström K. Addition of testosterone to estrogen replacement therapy in oophorecto-mized women: effects on sexuality and well-being. Climacteric 2002;5:357–365.
   PubMed Web of Science ®Google Scholar
• Davidson BJ, Ross RK, Paganini-Hill A. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Chin Endocrinol Metab 1982;54:115–120.
   Google Scholar
• Longcope C, Baker RS, Hui SL. Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 1984;6:309–318.
   Google Scholar
• Garnett T, Studd JWW, Watson N. The effects of plasma oestradiol levels on increases in vertebral and femoral bone density following therapy with oestradiol and oestradiol with testosterone implants. Obstet Gynecol 1992;79: 968–972.
   Google Scholar
• Watts NB, Notelovitz M, Timmons MC. Comparison of oral estrogens and estrogen plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529–537.
   Google Scholar
• Barrett-Connor E, Young R, Notelovitz M. A two-year double-blind comparison of estrogen-androgen and conju-gated estrogens in surgically PM women: effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999;44:1012–1020.
   Google Scholar
• Raisz LG, Wiita B, Ards A. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Chin Endocrinol Metab 1996;81:37–43.
   Google Scholar
• Colvard DS, Eriksen EF, Keeling PE. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 1989;86:854–887.
   PubMed Web of Science ®Google Scholar
• Sands RH, Studd JWW, Jones J. Comparison of the biochemical effects of testosterone and estrogen on bone markers in surgically postmenopausal women. Gynecol En-docrinol 2000;14:382–387.
   Google Scholar
• Risteli J, Elomaa I, Niemi S. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Chin Chem 1993;39:635–640.
   Google Scholar
• Melkko J, Kauppila S, Niemi S. Immunoassay for the intact aminoterminal propeptide of human type I procollagen. Chin Chem 1996;42:947–954.
   Google Scholar
• Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305–311.
   Google Scholar
• Clemmons D. Editorial: role of insulin-like growth factor-I in reversing catabolism. J Chin Endocrinol Metab 1992;75:1183–1185.
   PubMed Web of Science ®Google Scholar
• Morales AJ, Nolan H, Nelson JC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360–1367.
   Google Scholar
• Blum WF, Ranke MB. Plasma IGFBP-3 levels as clinical indicators. In: Spencer EM, editor. Modern concepts of insulin-like growth factors. New York: Elsevier Science Publishing; 1991. pp 381–393.
   Google Scholar
• Davis SR, Walker KZ, Strauss BJG. Effects of estradiol with and without testosterone on body composition and relation-ships with lipids in postmenopausal women. Menopause 2000;7:395–401.
   Google Scholar
• Lapidus L, Bengtsson C, Björntorp P. The quantitative relationship between the metabolic syndrome and abdominal obesity in women. Obes Res 1994;2:372–387.
   Google Scholar
• Horst HJ, Höltje WJ, Dennis M. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr 1976;54:875–879.
   PubMedGoogle Scholar
• Shackleford DM, Faassen WA, Houwing N. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J Pharmacol Exp Ther 2003;306:925–933.
   Google Scholar
• Flöter A, Nathorst-Böös J, Carlström K. Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy. Maturitas 2004;47:123–129.
   PubMed Web of Science ®Google Scholar
• Södergard R, Bäckström T, Shanbag V. Calculation of free and bound fractions of testosterone and estradio1-1713 to plasma proteins at body temperature. J Steroid Biochem 1982;18:801–804.
   Google Scholar
• Brismar TB, Ringertz H. Effect on bone density of the head on total body DEXA measurements in 100 healthy Swedish women. Acta Radiol 1996;37:101–106.
   Google Scholar
• Notelovitz M. Effects of estrogen/androgen therapy on bone mineral density parameters. J Reprod Med 2001;46:325–331.
   Google Scholar
• Gruber DM, Sator MO, Kirchengast S. Effects of percuta-neous replacement therapy on body composition and body weight in postmenopausal women. Maturitas 1998;29:253–259.
   Google Scholar
• Dobs AS, Nguyen T, Pace C. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Chin Endocrinol Metab 2002;87:1509–1516.
   Google Scholar
• Abrahamsen B, Bonnevie-Nielsen V, Ebbesen EN. Cytokines and bone loss in a 5-year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1 receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res 2000;15:1545–1554.
   PubMed Web of Science ®Google Scholar
• Ohta H, Makita K, Suda Y. Influence of oophorectomy on serum levels of sex steroids and bone metabolism and assessment of bone mineral density in lumbar trabecular bone by QCT-C value. J Bone Miner Res 1992;7:659–665.
   Google Scholar
• Kassem M, Okazaki R, Harris SA. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 1998;62:60–66.
   Google Scholar
• Wreje U, Brynhildsen J, Aberg H. Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use. Contraception 2000;61:265–270.
   Google Scholar
• Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study. J Chin Endocrinol Metab 1996;81:3469–3475.
   Google Scholar
• Douchi T, Yamamoto S, Nakamura S. The effect of menopause on regional and total body lean mass. Maturitas 1998;29:247–252.
   Google Scholar
• Guo SS, Zeller C, Chumlea WC. Aging, body composition and lifestyle: the Fels Longitudinal Study. Am J Chin Nutr 1999;70:405–411.
   Google Scholar
• Lovejoy JC, Bray GA, Bourgeois MO. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - a clinical research center study. J Chin Endocrinol Metab 1996;81:2198–2203.
   Google Scholar
• Wahab M, Ballard P, Purdie DW. The effect of long-term estradiol implantation on bone mineral density in postmeno-pausal women who have undergone hysterectomy and bilateral oophorectomy. Br J Obstet Gynaecol 1997;104:728–731.
   Google Scholar
• Khastgir G, Studd J, Holland N. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteo-porosis: histomorphometric evidence in a longitudinal study. J Chin Endocrinol Metab 2001;86:289–295.
   Google Scholar
• Ortmann J, Prifti S, Bohlmann MK. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol Endocrinol 2002;16: 113–120.
   Google Scholar
• Dimitrakakis C, Zhou J, Wang J. A physiological role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10:292–298.
   Google Scholar